Arvinas, Inc. (ARVN) stock
ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.82+0.05 (+0.74%)
Close on Nov 17, 2026Market cap $445.93MP/E 42.6Yield –
Arvinas total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Arvinas's total debt was $500.00K at Jun 30, 2026. For fiscal 2025 it was $600.00K, down 25.0% from the year before. The highest annual figure on record is $2.15M in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $600.00K | -25.0% |
| FY2024 | Dec 31, 2024 | $800.00K | -20.0% |
| FY2023 | Dec 31, 2023 | $1.00M | 0.0% |
| FY2022 | Dec 31, 2022 | $1.00M | 0.0% |
| FY2021 | Dec 31, 2021 | $1.00M | -50.0% |
| FY2020 | Dec 31, 2020 | $2.00M | 0.0% |
| FY2019 | Dec 31, 2019 | $2.00M | -7.2% |
| FY2018 | Dec 31, 2018 | $2.15M | +594.1% |
| FY2017 | Dec 31, 2017 | $310.39K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $500.00K | -28.6% |
| Q1 FY2026 | Mar 31, 2026 | $500.00K | -28.6% |
| Q4 FY2025 | Dec 31, 2025 | $600.00K | -25.0% |
| Q3 FY2025 | Sep 30, 2025 | $600.00K | -25.0% |
| Q2 FY2025 | Jun 30, 2025 | $700.00K | -22.2% |
| Q1 FY2025 | Mar 31, 2025 | $700.00K | -22.2% |
| Q4 FY2024 | Dec 31, 2024 | $800.00K | -20.0% |
| Q3 FY2024 | Sep 30, 2024 | $800.00K | -20.0% |
| Q2 FY2024 | Jun 30, 2024 | $900.00K | -10.0% |
| Q1 FY2024 | Mar 31, 2024 | $900.00K | -10.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.00M | 0.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.00M | 0.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.00M | 0.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.00M | 0.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.00M | 0.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.00M | 0.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.00M | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | $1.00M | -50.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.00M | -50.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.00M | -50.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.00M | -50.0% |
| Q1 FY2021 | Mar 31, 2021 | $2.00M | 0.0% |
| Q4 FY2020 | Dec 31, 2020 | $2.00M | 0.0% |
| Q3 FY2020 | Sep 30, 2020 | $2.00M | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.00M | -3.5% |
| Q1 FY2020 | Mar 31, 2020 | $2.00M | -5.4% |
| Q4 FY2019 | Dec 31, 2019 | $2.00M | -7.2% |
| Q3 FY2019 | Sep 30, 2019 | $2.00M | -8.9% |
| Q2 FY2019 | Jun 30, 2019 | $2.07M | +567.4% |
| Q1 FY2019 | Mar 31, 2019 | $2.11M | – |
| Q4 FY2018 | Dec 31, 2018 | $2.15M | – |
| Q3 FY2018 | Sep 30, 2018 | $2.19M | – |
| Q4 FY2017 | Dec 31, 2017 | $310.39K | – |
See a number that looks wrong?